| Followers | 22 |
| Posts | 1626 |
| Boards Moderated | 1 |
| Alias Born | 09/25/2018 |
Saturday, October 12, 2024 1:21:36 PM
No. Apple's actual trading price in the market was never below $1. You're still not understanding the impact of stock splits.
AAPL stock has split several times over the decades.
June 16, 1987: 2-for-1
June 21, 2000: 2-for-1
February 28, 2005: 2-for-1
June 9, 2014: 7-for-1
August 28, 2020: 4-for-1
Multiply those for a cumulative total of 224 for 1. If you had a single share of AAPL at the start of 1987, you would have 224 shares today.
Those sub-$1 prices you see in the history are SPLIT-ADJUSTED!!!!!!! They are not what AAPL traded for in the stock market.
To find the actual trading prices in the 1980s you need to multiply the split-adjusted price by the split factor of 224x.
You might be confused because the history of nwbo includes REVERSE splits. 1 for 16 in 2012, 1 for 15 in 2007.
Back in 2002 nwbo never traded over $1000 in the market. Those split-adjusted prices need to be divided by 240 to see the
actual stock market prices.
AAPL stock has split several times over the decades.
June 16, 1987: 2-for-1
June 21, 2000: 2-for-1
February 28, 2005: 2-for-1
June 9, 2014: 7-for-1
August 28, 2020: 4-for-1
Multiply those for a cumulative total of 224 for 1. If you had a single share of AAPL at the start of 1987, you would have 224 shares today.
Those sub-$1 prices you see in the history are SPLIT-ADJUSTED!!!!!!! They are not what AAPL traded for in the stock market.
To find the actual trading prices in the 1980s you need to multiply the split-adjusted price by the split factor of 224x.
You might be confused because the history of nwbo includes REVERSE splits. 1 for 16 in 2012, 1 for 15 in 2007.
Back in 2002 nwbo never traded over $1000 in the market. Those split-adjusted prices need to be divided by 240 to see the
actual stock market prices.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
